摘要
目的比较fas基因和bcl2基因在胃癌耐药细胞与非耐药细胞表达的差异,将fas基因和bcl2反义核酸导入胃癌耐药细胞,并分析转导前后的细胞在mRNA与蛋白的表达水平,研究转导株与非转导株对化疗药物敏感性的区别.方法采用分子克隆技术将fas基因和反义bcl2片段分别插入真核表达载体pBKCMV和pDORSV40的多克隆克隆位点之间,以脂质体介导法将两个重组表达载体分别转染受体细胞SGC7901/VCR,G418筛选克隆细胞,Northernblot,Westernblot检测耐药细胞与非耐药细胞以及转导细胞中fas基因和bcl2基因mRNA及其蛋白的表达,MTT法药敏实验检测转导细胞与非转导细胞对VCR、顺铂、5FU的敏感性.结果真核表达载体pBKfascDNA和pDORbcl2cDNA转导胃癌耐药细胞后,分别从2×105细胞中筛选出大约80和120个抗性克隆,转导率各为04‰和06‰,随机各挑选2个克隆继续筛选与扩增培养,均获得了稳定的抗性细胞,我们将此命名为SGC7901fas/VCRcel和SGC7901antibcl2/VCRcel.杂交结果表明,胃癌耐药细胞SGC7901/?
AbstractAIM To compare the expression level of fas gene and bcl-2 gene in gastric cancer cells SGC7901 and in gastric cancer MDR cells SGC7901/VCR, to transduce fas cDNA and bcl-2 antisense nucleic acid into SGC7901/VCR cells respectively, and to observe the expression of two genes in transfectants and nontransfectants as well as their drug sensitivity.METHODS The eukaryotic expression vector pBKfas and pDORanti bcl-2 was constructed, and then transfected into SGC7901/VCR cells by lipofectamine, respectively. The expression of mRNA and protein in SGC7901/VCR cells and SGC7901 cells and transfectants was detected using Northern blot and Western blot and the drug sensitivity of transfectants for VCR, CDDP and 5FU was analysed with MTT assay.RESULTS After gene transfection, 80 for fas or 120 for antisense bcl-2 drugresistant clones were selected from 2×10~5 cells, the transfection efficiency was 0.04% and 006%, respectively. Two clones, SGC7901 fas/VCR cells and SGC7901 anti-bcl-2/VCR cells, were randomly selected for further incubation. Hybridization results showed that the expression level of fas mRNA and protein in SGC7901/VCR cells was much lower, but the expression level of bcl2 mRNA and protein was higher than that in SGC7901 cells, the expression level of fas mRNA and protein in SGC7901 fas/VCR cells was higher, and the expression level of bcl2 mRNA and protein was lower in SGC7901 anti bcl-2/VCR cells than that in nontransfectants. MTT assay showed that transfectants were more sensitive to VCR, CDDP and 5FU than nontransfectants.CONCLUSION bcl-2 gene displayed high expression and fas gene displayed low expression in drug resistant gastric cancer cells. Expression of bcl-2 protein was effectively blocked in SGC7901 anti bcl-2/VCR cells by gene transfection, in contrast, the expression of fas mRNA and protein in SGC7901 fas/VCR cells increased. Fas gene and bcl-2 antisense nucleic acid transfection sensitized drug resistant gastric cancer cells to chemotherapeutic drugs.